Diabetes
Diabetes
THE EPIDEMIOLOGY OF TYPE 2 DIABETES MELLITUS
COMPETING ETIOLOGICAL HYPOTHESES: NURTURE VERSUS NATURE
RACIALIZATION: SOCIAL DESCRIPTIONS VERSUS BIOLOGICAL ATTRIBUTIONS
DIABETES AS A BIOCULTURAL DISEASE
Starting in the second half of the twentieth century, the prevalence of non-insulin-dependent (type 2) diabetes increased substantially in many populations and ethnic groups, including African Americans, Native Americans, Mexicans Americans, and Pacific Islanders. Diabetes is a metabolic disorder characterized by an inability to regulate blood sugar. The increase in this disease is clearly related to shifts in diet and lifestyle. While some researchers have proposed that it is related to genetic factors, other researchers point to stressful and challenging life conditions resulting from poverty and social inequality.
THE EPIDEMIOLOGY OF TYPE 2 DIABETES MELLITUS
More than 90 percent of all diabetics have type 2 diabetes. Unlike the more rare form of the disease, type 1 diabetes, people with type 2 diabetes produce insulin and therefore seldom need therapeutic insulin at the initial onset of the disease. Type 2 diabetes is considered a late-onset chronic disease and is associated with risk factors such as increased obesity, dietary fat intake, smoking, and low physical activity. Racism, stress, and socioeconomic status have also been implicated in the development of diabetes. Diabetes is diagnosed by measuring the percentage of red blood cells that are bound with glucose. There is no cure for diabetes, but the traditional treatment includes alterations in diet, exercise, and drug therapies to control glucose metabolism.
Prevalence rates follow a strikingly similar pattern in varied populations. For First Nations Canadian men and women, age-adjusted prevalence rates are 3.6 and 5.5 times higher, respectively, than among the general Canadian population. Among Indigenous Australians, the prevalence rates are almost four times higher than the rate for the non-Indigenous population. Researchers comparing age-adjusted prevalence rates for Nigerians and people of African origin living elsewhere found diabetes rates were
2.5 to 5 times higher for those living in the Caribbean and United Kingdom. In the United States, the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) estimates that at least 8 to 10 percent of all Latinos, African Americans, and Native Americans aged twenty years or older have diabetes. The comparable prevalence rates for non-Hispanic whites is 4.8 percent.
According to the U.S. Centers for Disease Control and Prevention (CDC), diabetes is the seventh leading cause of death in the United States. The World Health Organization (WHO) has called diabetes an emerging epidemic, with more than 16 million people affected in the United States and millions more in the rapidly urbanizing Southern Hemisphere and China. According to the WHO, approximately 366 million people worldwide will have diabetes by 2025. The very similar epidemiological patterns that exist for U.S. minorities, First Nations Canadians, Indigenous Australians, peoples of the African diaspora, and peoples of the Pacific Islands strongly indicate that diabetes disproportionately affects subordinated groups around the world.
COMPETING ETIOLOGICAL HYPOTHESES: NURTURE VERSUS NATURE
Type 2 diabetes (hereafter referred to simply as diabetes), like heart disease, hypertension, and asthma, is a complex disease because its putative risks lay in both environmental and biological domains. That is, diabetes is caused by an as yet unknown combination of factors such as lifestyle, diet, physical activity, and an array of physiological triggers. The relative overburden of diabetes on people whose social histories contain violent and radical disruptions of their lifeways has not resulted in any real agreement about its cause. Rather, diabetes has engendered competing etiological hypotheses. For simplicity, these three competing theories will be named the social conditions, the fetal origins, and the thrifty genotype hypothesis respectively.
Research into the social conditions that impact diabetogenesis has generated considerable evidence for the link between stress and glucose metabolic impairment. Life conditions such as experiences of racism, poverty, and job insecurity have all been associated with measured levels of elevated blood glucose. These findings clearly suggest that the epidemiological patterns of diabetes reflect sociocultural conditions in nonrandom ways. For example, the increased prevalence of diabetes within Native American, Latino, and African-American groups can be attributed to the differential experiences of social inequality these groups endure compared to nonwhite Hispanics. Similarly, the increasing rates of diabetes in geographic areas where human populations are rapidly moving to urban areas suggests that the disease may be an index of the stressors of rural-to-urban migration and lifeways disruptions resulting from the profound political and economic dislocations required for flexible labor markets.
Researchers looking for physiological causes of diabetes investigate conditions during fetal development as primarily responsible for the disease. This hypothesis, also called the thrifty phenotype hypothesis, the developmental hypothesis, or the fetal origins hypothesis, proposes that poor fetal conditions, such as those that cause low birth weight, impair the in-utero development of the glucose-insulin physiological systems. Research in a number of populations and animal studies suggests that the fetus adapts itself to its developmental environment as a preparatory response to postnatal life conditions. Because low birth weight is also associated with the deprivations often linked to social inequality, the fetal origins hypothesis implicates historical and contemporary systems of social stratification as causally linked to disease outcomes in groups with these experiences. Fetal origins research offers physiological evidence that social and environmental conditions related to social inequality can impact developmental gene expression and lead to impaired health in adult life.
The other dominant theory for the pronounced differences in the prevalence of diabetes, and perhaps the oldest, is the thrifty genotype hypothesis. Research into this hypothesis attempts to explain disparities in disease patterns between human groups as a function of evolutionary pressures. One of the oldest gene-based theories of chronic disease causation, the thrifty genotype hypothesis postulates the existence of an evolutionarily and advantageous genetic predisposition to the efficient metabolic storage and utilization of caloric energy— a predisposition rendered “maladaptive” by the contemporary widespread overabundance of food. The thrifty genotype hypothesis has enjoyed more than four decades of concerted research attention, coinciding with, and in many respects developing alongside, the molecular revolution.
In this model, disparities in diabetes between various ethnoracial groups are often attributed to the genetic triggering of the “thrifty genes” that are presumed to result from the transition to urban, sedentary lifestyles. The original proponent of the thrifty genotype hypothesis, geneticist James Neel (1915–2000), considered diabetes a condition of environmental origins. In his final statement on diabetes, Neel found “no support to the notion that high frequency of NIDDM [non-insulin-dependent diabetes mellitus] in reservation Amerindians might be due simply to an ethnic predisposition—rather, it must predominantly reflect lifestyle changes” (Neel 1999, p. S3). Still, the thrifty genotype model has widespread allegiance and fuels millions of dollars in research activity.
RACIALIZATION: SOCIAL DESCRIPTIONS VERSUS BIOLOGICAL ATTRIBUTIONS
The technical, methodological, and conceptual premises of the gene-based hypothesis have engendered considerable ethical debates surrounding the use of socially labeled populations for studies of complex diseases like diabetes. Underlying these current debates are laudable goals of disease prevention and harm reduction for all persons, especially descendants of the formerly enslaved or colonized. Yet the persistence of these concerns, in and out of academe, signals a fundamentally sociocultural phenomenon that will not be resolved by attention to analytical considerations alone and will involve complex sociological and cultural factors.
First, owing to advances in genomic biology, genetics-based models of diabetes causation now have considerable advantages in competition for research attention. Researchers claim that finding genetic contributions to complex diseases is the first step to understanding physiology and subsequent drug interventions. In nations where public health infrastructures are already suffering from neglect, the policy impulse to advance a gene-based research that promises drug therapies for the most costly diseases is understandable. Yet while public health interventions to prevent tobacco use, require seat belts, provide prenatal care, and make vaccinations widely available have been proven to be cost effective, no such proof exists for gene-based research into complex diseases such as diabetes. Thus, there is reason to dispute the high investment in capital and human talent for scientific hypotheses that have little translatable application toward disease prevention and treatment.
Second, the use of genetic variation hypotheses to explain ethnoracial differences in complex diseases is a particular form of racialization, which is “a dialectical process by which meaning is attributed to particular biological features of human beings, as a result of which individuals may be assigned to a general category of persons that reproduces itself biologically” (Miles and Brown 2003, p. 102). In other words, racialization is the attribution of innate fixed biological differences between human groups labeled with ethnic, cultural, national, political, or geographical taxonomies. It does not refer to descriptive taxonomic structures, which are the labels humans use to identify themselves or others. Rather, racialization occurs when these descriptions are used in a manner that ascribes a somatic innate and fixed difference between the labeled groups. In the descriptive mode, the labels black, African American, Latino, Mexicano, or white are labels used as identifiers. Yet these identifiers have been shown time and again to be historically and situationally determined, unreliable, and invalid proxies for biological human differences.
Socially derived group labels, at best, work like pronouns, always requiring specification and never defining the person or thing to which the pronoun refers. In the attributive mode, these labels are used to ascribe fixed, innate attributes to the bodies of human groups. This occurs, for example, when geneticists studying diabetes use “Mexicano” as a label and attach to it the meanings of biological features that differentiate Mexicanos from other human groups. When inequalities of morbidity and mortality of a disease such as diabetes are explained or hypothesized as a condition of innate and fixed biological differences among groups, the existence of sociopolitical inequalities between human groups are effectively overlooked, and the related embodied health outcomes are, by default, attributed to biological differences.
Racialization must be distinguished from the descriptions of humans used in studies that measure different health outcomes not attributed to evolution or to the discovery of biogenetic characteristics of one human group. These studies use ethnoracial labels to describe the social histories of health phenomena, the social epidemiology of disease, and the health consequences of sociopolitical phenomena—or to simply socially identify those human groups most impacted by a disease. A nonracialized understanding of disease patterns avoids the biological determinism that is inherent in racialization.
DIABETES AS A BIOCULTURAL DISEASE
As a racializing practice, gene-based approaches to diabetes advance the myth that biology can explain social phenomena. In fact, considerable evidence suggests that biology and social phenomena are co-produced, that biological and social phenomena develop in mutually interdependent ways. In its most crude form, this is evident when genetic researchers use social labels to describe human groups, which renders their findings both biological and social in origin. Similarly, researchers using evolutionary models for complex diseases require genetic samples of the populations most impacted by diabetes. They are thus investigating the physiological impact of social stratification and the radical lifestyle transformation required of advanced capitalism.
Viewing complex disease through a genetic lens is a long-established sociocultural phenomenon, one that has been applied to diseases such as sickle-cell anemia, hypertension, and diabetes. For diabetes, the alleged metabolic adaptation within the thrifty genotype hypothesis presumes that hunter-gatherers experienced severe episodes of feast and famine. Selective evolutionary pressures would therefore favor those whose metabolism would best convert glucose to fat for use during periods of food scarcity. Contemporary human groups impacted by diabetes are viewed as genetically predis-posed to the disease by virtue of their current similarity to the lifeways of earlier humans. However, both the extent of the feast-and-famine cycles of hunter-gatherers and the association of contemporary human groups with early human life-ways are unsubstantiated premises, relying on presumed rather than empirically supported benefits of modernity. The widespread adherence to the evolutionary hypothesis of diabetes (and the considerable resources directed toward such studies) is another iteration of a race theory that advances the cultural notion that diabetes affects human groups differently because of innate genetic differences.
Examining diabetes as an evolutionary trait denies the impact of the social dislocation, dispossession, colonization, slavery, racism, and other sociohistorical impact on those groups affected by diabetes. For example, the groups most disproportionately impacted by diabetes, Native Americans, experienced extreme deprivations during the violent dispossession of their lands and subsequent attempts by white settlers to eradicate them. It is the children and grandchildren of those born during this period who now suffer disproportionately from diabetes. These conditions support the fetal origins hypotheses and do not require the logical leap that such recent experiences could have evolutionary significance, and thus result in genotypic human variation. Thus, the widespread adherence to the genetic predisposition thesis for diabetes reflects a dominant cultural way of making sense of relations between groups impacted by the disease.
In order to understand the causes of diabetes, its evolutionary hypothesis must be seen as fitting not the natural history of the disease, but rather the ideological premise of a subordinating majority whose scientists refuse to seriously account for the social history of those peoples most impacted by the disease. Researchers seriously interested in preventing diabetes would greatly benefit by approaching the disease in ethnoracial groups as a biocultural phenomenon. To avoid merely reproducing another unprovable evolutionary genetic predisposition claim, researchers must carefully investigate diabetes as the biological impact of economic and sociocultural changes for human life. This requires uncommon multi-disciplinary methods spanning the biological and social sciences and humanities. More importantly, researchers must actively counter the racialized hypothesis of genetic predisposition, especially in research into health inequalities among minority and emerging majority groups in parts of the world with high levels of ethnoracial stratification and an unequal distribution of resources. In short, researchers must recognize the link between diabetes and institutional racism.
SEE ALSO Diseases, Racial.
BIBLIOGRAPHY
Australian Bureau of Statistics. 2002. National Health Survey: Aboriginal and Torres Strait Islander Results, Australia, 2001. Canberra: Australian Bureau of Statistics. Available from http://www.abs.gov.au.
Barker, David. J. 2005. “The Developmental Origins of Insulin Resistance.” Hormone Research 64 (Suppl. 3): 2–7. Available from http://content.karger.com.
Benyshek, Daniel C., John F. Martin, and Carol S. Johnston. 2001. “A Reconsideration of the Origins of the Type 2 Diabetes Epidemic among Native Americans and the Implications for Intervention Policy.” Medical Anthropology 20 (1): 25–44.
Cooper, Richard S., et al. 1997. “Prevalence of NIDDM among Populations of the African Diaspora.” Diabetes Care 20 (3): 343–348.
Foliaki, Sunai, and Neil Pearce. 2003. “Prevention and Control of Diabetes in Pacific People.” British Medical Journal 327: 437–439.
Goodman, Alan H., and Thomas L. Leatherman, eds. 1998. Building a New Biocultural Synthesis: Political-Economic Perspectives on Human Biology. Ann Arbor: University of Michigan Press.
Hales, C. Nicholas, and David J. Barker. 2001. “The Thrifty Phenotype Hypothesis.” British Medical Bulletin 60 (1): 5–20.
Karlsen, Saffron, and James Y. Nazroo. 2002. “Relation between Racial Discrimination, Social Class, and Health among Ethnic Minority Groups.” American Journal of Public Health 92 (4): 624–631.
Kaufman, Jay, and Richard Cooper. 2001. “Commentary: Considerations for Use of Racial/Ethnic Classification in Etiologic Research.” American Journal of Epidemiology 154 (4): 291–298.
Krieger, Nancy, ed. 2005. Embodying Inequality: Epidemiologic Perspectives. Amityville, NY: Baywood.
Maty, S. M., et al. 2002. “Interaction between Childhood Socioeconomic Position, Adult Body Mass Index and 34-year Incidence of Type 2 Diabetes Mellitus.” Annals of Epidemiology 12 (7): 501–502.
Miles, Robert, and Malcolm Brown. 2003. Racism. New York: Routledge.
Neel, James V. 1962. “Diabetes Mellitus: A ‘Thrifty’ Genotype Rendered Detrimental by Progress?” American Journal of Human Genetics 14: 353–362.
———. 1999. “The ‘Thrifty Genotype’ in 1998.” Nutrition Reviews 57 (5): S2-S9.
Quinn, Laurie. 2003. “Behavior and Biology: The Prevention of Type 2Diabetes.” Journal of Cardiovascular Nursing 18 (1): 62–68.
Sahlins, Marshal. 1972. Stone Age Economics. Chicago: Aldine.
Szathmary, Emoke, and R. E. Ferrel. 1990. “Glucose Level, Acculturation, and Glycosylated Hemoglobin: An Example of Biocultural Interaction.” Medical Anthropological Quarterly 4 (3): 315–341.
Young, T. Kue, Jeff Reading, Brenda Elias, and John D. O’Neil. 2000. “Type 2 Diabetes Mellitus in Canada’s First Nations: Status of an Epidemic in Progress.” Canadian Medical Association Journal 163 (5): 561–566.
Michael J. Montoya
